Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition

Molecular Psychiatry

Volumn 16, Issue 8, 2011, Pages 860-866

  Morar, B ^a   Dragovic M ^b   Waters, F A V ^b   Chandler, D ^a   Kalaydjieva, L ^a   Jablensky, A ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

chizophrenia; cognitive endophenotypes; degraded stimulus continuous performance task; NRG3

Indexed keywords

NEU DIFFERENTIATION FACTOR; NEUREGULIN 3; UNCLASSIFIED DRUG;

ADULT; ALERTNESS; ALLELE; ARTICLE; CHROMOSOME 10Q; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DELUSION; EXON; FLORID DELUSION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; PERCEPTION; POST HOC ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; THOUGHT DISORDER;

CASE-CONTROL STUDIES; COGNITION DISORDERS; ENDOPHENOTYPES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEUREGULINS; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 79960836284     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2010.70     Document Type: Article

References (31)

1. Chen PL, Avramopoulos D, Lasseter VK, McGrath JA, Fallin MD, Liang KY et al. Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. Am J Hum Genet 2009; 84: 21-34.
2. McGrath JA, Avramopoulos D, Lasseter VK, Wolyniec PS, Fallin MD, Liang KY et al. Familiality of novel factorial dimensions of schizophrenia. Arch Gen Psychiatry 2009; 66: 591-600.
3. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003; 284: 14-30. (Pubitemid 36335807)
4. Carpenter G. ErbB-4: mechanism of action and biology. Exp Cell Res 2003; 284: 66-77. (Pubitemid 36331966)
5. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877-892. (Pubitemid 135750519)
6. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 50 SNPs associated with the disease. Proc Natl Acad Sci USA 2006; 103: 6747-6752.
7. Tan W, Wang Y, Gold B, Chen J, Dean M, Harrison PJ et al. Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem 2007; 282: 24343-24351. (Pubitemid 47328000)
8. Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D et al. Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet 2003; 73: 601-611. (Pubitemid 37076272)
9. Faraone SV, Hwu HG, Liu CM, Chen WJ, Tsuang MM, Liu SK et al. Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. Am J Psychiatry 2006; 163: 1760-1766. (Pubitemid 44522485)
10. Balciuniene J, Feng N, Iyadurai K, Hirsch B, Charnas L, Bill BR et al. Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities. Am J Hum Genet 2007; 80: 938-947. (Pubitemid 46668462)
11. Benzel I, Bansal A, Browning BL, Galwey NW, Maycox PR, McGinnis R et al. Interactions among genes in the ErbBNeuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct 2007; 3: 31.
12. Wang YC, Chen JY, Chen ML, Chen CH, Lai IC, Chen TT et al. Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population. Biol Psychiatry 2008; 64: 1093-1096.
13. Xu B, Woodroffe A, Rodriguez-Murillo L, Roos JL, van Rensburg EJ, Abecasis GR et al. Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc Natl Acad Sci USA 2009; 106: 16746-16751.
14. Hallmayer JF, Kalaydjieva L, Badcock J, Dragovic M, Howell S, Michie PT et al. Genetic evidence for a distinct subtype ofschizophrenia characterized by pervasive cognitive deficit. Am J Hum Genet 2005; 77: 468-476. (Pubitemid 41192652)
15. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Jablensky A et al. SCAN: Schedules For Clinical Assessment In Neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-593. (Pubitemid 20189971)
16. Castle DJ, Jablensky A, McGrath JJ, Carr V, Morgan V, Waterreus A et al. The diagnostic interview for psychoses (DIP): development, reliability and applications. Psychol Med 2005; 36: 69-80.
17. Manton KG, Woodbury MA, Tolley DH. Statistical Applications Using Fuzzy Sets. John Wiley: NewYork, 1994.
18. Purcell S, Neale B, Todd-Brown K, Thomas L, FerreiraMA, Bender D et al. PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
19. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry 2006; 11: 815-836. (Pubitemid 44299104)
20. Waters FA, Badcock JC, Dragovic M, Jablensky A. Neuropsychological functioning in schizophrenia patients with first-rank (passivity) symptoms. Psychopathology 2009; 42: 47-58.
21. Schneider K. Clinical Psychopathology (trans. MW Hamilton) Grune and Stratton: New York, 1959.
22. Nuechterlein KH. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. J Abnorm Psychol 1983; 92: 4-28.
23. Siegel BV, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics and controls. Schizophr Res 1995; 17: 85-94.
24. Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ et al. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull 2007; 33: 49-68. (Pubitemid 46026259)
25. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. PNAS 2003; 100: 6186-6191. (Pubitemid 36576952)
26. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AFT. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 2007; 10: 376-384.
27. Christie-Fougere MM, Darby-King A, Harley CW, McLean JH. Calcineurin inhibition eliminates the normal inverted U curve, enhances acquisition and prolongs memory in a mammalian 30-50- cyclic AMP-dependent learning paradigm. Neuroscience 2009; 158: 1277-1283.
28. Longart M, Liu Y, Karavanova I, Buonanno A. Neuregulin-2 is developmentally regulated and targeted to dendrites of central neurons. J Comp Neurol 2004; 472: 156-172. (Pubitemid 38429017)
29. Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Yet al. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA 1997; 94: 9562-9567. (Pubitemid 27408101)
30. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004; 101: 6062-6067. (Pubitemid 38520528)
31. Carteron C, Ferrer-Montiel A, Cabedo H. Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J Cell Sci 2006; 119: 898-909.